Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Marshall Teitelbaum who wrote (1683)	10/31/1998 2:46:00 AM
From: WWS	Respond to of 2205

Marshall, one of the tissue culture companies might want to look into commercial rights to regenerating human fetal cells from the CNS: biz.yahoo.com

To: Marshall Teitelbaum who wrote (1683)	11/5/1998 9:54:00 AM
From: Rick Strange	Respond to of 2205

Marshall, interesting patent assigned to ATIS Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue. Abstract: A tissue engineering bioreactor is disclosed for growing three-dimensional tissue. Cells are seeded onto a mesh and provided with two media flows, each contacting a different side of the cells. (MicroPatent, 271 words) I don't have access to the complete report, if someone does could they please give a bit more detail? I'd like to see the Company put out a press release about this new patent and explain its application.